UK shareholder meetings calendar - next 7 days
23rd Jun 2026 12:42
| Price | 492.00p on 17-08-2026 at 18:25:05 |
|---|---|
| Change | -58.00p -10.55% |
| Buy | 500.00p |
| Sell | 484.00p |
| Last Trade: | Sell 75.00 at 484.80p |
| Day's Volume: | 2,655 |
| Last Close: | 492.00p |
| Open: | 525.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 492.00p - 550.00p |
| 52wk Range: | 425.00p - 890.00p |
| Market Capitalisation: | £76.19m |
| VWAP: | 507.18085p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 75 | 484.80p | Ordinary |
15:19:45 - 17-Aug-26 |
| Sell* | 1 | 484.80p | Ordinary |
15:19:45 - 17-Aug-26 |
| Sell* | 100 | 484.80p | Ordinary |
15:19:45 - 17-Aug-26 |
| Sell* | 96 | 484.36p | Ordinary |
15:09:29 - 17-Aug-26 |
| Sell* | 200 | 500.00p | Ordinary |
15:09:20 - 17-Aug-26 |
| Sell* | 550 | 504.266p | Ordinary |
12:31:27 - 17-Aug-26 |
| Buy* | 1 | 550.00p | Suspected BUY Trade |
11:00:25 - 17-Aug-26 |
| Unknown* | 1,500 | 513.30p | Ordinary |
09:50:50 - 17-Aug-26 |
| Sell* | 37 | 516.50p | Ordinary |
09:45:38 - 17-Aug-26 |
| Unknown* | 0 | 550.00p | SI Trade |
08:34:42 - 17-Aug-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Jul 2026 7:00 am | PRN | Grant of Options & Director/PDMR Dealing |
| 8th Jul 2026 7:00 am | PRN | Director Appointment |
| 30th Jun 2026 5:37 pm | PRN | Result of AGM & Issue of Options |
| 16th Jun 2026 7:00 am | PRN | Notice of Investor Presentation |
| 15th Jun 2026 7:00 am | PRN | 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board |
| 5th Jun 2026 7:00 am | PRN | Notice of Annual General Meeting |
| 22nd May 2026 9:10 am | PRN | Director Dealing |
| 20th May 2026 7:02 am | PRN | Final Results and Notice of AGM |
| 20th May 2026 7:00 am | PRN | 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial |
| 14th May 2026 7:00 am | PRN | Appointment of Chief Financial Officer and Board Changes |